Cyclerion Therapeutics Inc. is a biopharmaceutical company focused on developing treatments for serious diseases. They use a unique approach to target soluble guanylate cyclase (sGC) to discover and develop potential therapies. With a strong pipeline of candidates, they aim to make a significant impact on patients’ lives.
Notification